Please login to the form below

Not currently logged in
Email:
Password:

M3 EU

This page shows the latest M3 EU news and features for those working in and with pharma, biotech and healthcare.

The digital race: Eight ways to get up-to-speed

The digital race: Eight ways to get up-to-speed

Across Health's 2016 study reveals that Europe lags behind the US and Japan - investing around 15% of its marketing spend on digital marketing,” says Tim Ringrose, CEO, M3 EU.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • M3 appoints Simon Walker as director of education M3 appoints Simon Walker as director of education

    M3 has appointed Simon Walker to lead its educational arm as it increases its multi-country med ed services. ... M3 EU’s CEO Tim Ringrose said: “I’d like to welcome Simon as our Education Director, a key appointment for M3.

  • M3 appoints Paul Rice as chief operating officer M3 appoints Paul Rice as chief operating officer

    Dr Tim Ringrose, CEO of M3 EU, said: “M3’s capabilities are becoming firmly established in key European markets and I’m delighted to welcome Paul to M3 as we continue ... to drive M3’s growth in key markets and expand the services we provide to

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Learning to invest in doctors’ education

    Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for more

  • Engaging doctors around the globe

    Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies are now exploring and exploiting a

  • How do doctors spend their time online?

    In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined. The specific habits of doctors around internet use are,

  • How do doctors want to engage with pharma on new products?

    New data from M3 Global Research shows EU doctors are optimistic about pharma’s ability to deliver new medicines, with 72% of them saying they are key to improving the outlook ... M3 Global Research put these questions to 1, 848 EU doctors mainly from

  • M3 Acquires MirVracha LCC in Russia Launching Full-Scale Development of Physician Platform Business in Russia

    M3 operates m3.com, a specialized web portal for medical professionals that delivers healthcare related information to its 300, 000+ physician members in Japan. ... that MirVracha has cultivated in Russia, with M3's expertise in operating websites and

More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....